Atlas Trials

The Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female Subjects

Clinical trial NCT03092102 · COMPLETED

Trial details

NCT number
NCT03092102
Sponsor
Sunshine Lake Pharma Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Idiopathic Pulmonary Fibrosis
Start date
2017-05-20
Primary completion
2019-02-25
Enrollment
136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.